(191 days)
Not Found
No
The description focuses on the physical components and functionality of a CPAP/bi-level therapy mask, with no mention of AI or ML.
No.
The device is a mask that provides an interface for application of CPAP or bi-level therapy, but it does not deliver the therapy itself, therefore it is not a therapeutic device.
No
This device is a mask intended to provide an interface for the application of CPAP or bi-level therapy, which is a treatment, not a diagnostic procedure.
No
The device description clearly outlines physical components like masks, cushions, elbows, headgear, and a frame, indicating it is a hardware medical device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the mask is "intended to provide an interface for application of CPAP or bi-level therapy to patients." This describes a device used to deliver a therapeutic treatment (air pressure) directly to a patient's respiratory system.
- IVD Definition: In vitro diagnostics are devices used to examine specimens (like blood, urine, or tissue) taken from the human body to provide information for diagnosis, monitoring, or screening. This mask does not perform any such analysis of biological specimens.
- Device Description: The description focuses on the physical components of the mask and its function in delivering air pressure. There is no mention of analyzing biological samples.
- Performance Studies: The performance studies listed are related to the physical and functional characteristics of the mask (pressure drop, leak, resistance, dead space, cleaning validation), not the analysis of biological samples.
Therefore, the AF541 EE Leak 1 and Leak 2 Masks are medical devices used for respiratory therapy, not in vitro diagnostics.
N/A
Intended Use / Indications for Use
AF541 EE Leak 1 Mask
The AF541 EE Leak 1 Full Face Mask is intended to provide an interface for application of CPAP or bi-level therapy to patients. The mask is for single use in the hospital/institutional environment only. The mask is to be used on patients (>40lbs/20kg) for whom CPAP or bi-level therapy has been prescribed.
AF541 EE Leak 2 Mask
The AF541 EE Leak 2 Full Face Mask is intended to provide an interface for application of CPAP or bi-level therapy to patients. The mask is for single use in the hospital/institutional environment and single patient use in the home. The mask is to be used on patients (>40lbs/20kg) for whom CPAP or bi-level therapy has been prescribed.
Product codes
BZD
Device Description
The AF541 EE Full Face Mask is an oral-nasal full face mask that is available in various configurations (cushions and elbows). The AF541 EE Full Face has two cushion configurations, an Over the Nose (OTN) cushion and an Under the Nose (UTN) cushion. The following elbow configurations are available: EE Leak 1 and EE Leak 2. The Leak 1 and Leak 2 elbows have an anti-asphyxia valve. In addition, the Leak 2 elbow has built in exhalation to provide intentional leak when needed.
The AF541 EE Full Face Mask will have interchangeable cushions that attach to a common frame. There will be four sizes available for the nose option (S, M, L, XL). The UTN option will have three sizes available (A, B, C).
The AF541 mask will include a 4-point headgear and capstrap to allow for oral access with either headgear option. There will be 22 mm female mask frame. The AF541 OTN and UTN will be compatible with the EE Leak 1 and EE Leak 2 elbow.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Nose and Mouth
Indicated Patient Age Range
The mask is to be used on patients (>40lbs/20kg) for whom CPAP or bi-level therapy has been prescribed.
Intended User / Care Setting
AF541 EE Leak 1 Mask: single use in the hospital/institutional environment only.
AF541 EE Leak 2 Mask: single use in the hospital/institutional environment and single patient use in the home.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Clinical tests were not required to demonstrate the substantial equivalence of the AF541 EE Full Face Mask. Product functionality has been adequately assessed by non-clinical tests.
Performance testing was performed before and after cleaning treatments to verify that the device modifications of the subject device did not raise new safety and effectiveness concerns. Performance testing included:
- Total Mask Pressure Drop
- Total Mask Leak
- Intentional Leak
- Inspiratory & Expiratory Anti-Asphyxia Feature Resistance
- Anti-Asphyxia Feature Close to Atmosphere
- Anti-Asphyxia Feature Open To Atmosphere
- Dead space
- CO2 Rebreathing
- Storage Temperature and Humidity
- Cleaning Validation
Key Metrics
Not Found
Predicate Device(s)
AF531 EE Full Face Mask (K101130)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 868.5905 Noncontinuous ventilator (IPPB).
(a)
Identification. A noncontinuous ventilator (intermittent positive pressure breathing-IPPB) is a device intended to deliver intermittently an aerosol to a patient's lungs or to assist a patient's breathing.(b)
Classification. Class II (performance standards).
0
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
September 18, 2015
Respironics, Inc. Ms. Shaylee Masilunas Regulatory Affairs Engineer 1001 Murry Ridge Lane Murrysville, PA 15668
Re: K150639
Trade/Device Name: AF541 EE Full Face Mask Regulation Number: 21 CFR 868.5905 Regulation Name: Noncontinuous Ventilator (IPPB) Regulatory Class: Class II Product Code: BZD Dated: August 14, 2015 Received: March 17, 2015
Dear Ms. Shaylee Masilunas:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in
1
the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Tejashri Purohit-Sheth, M.D.
Tejashri Purohit-Sheth, M.D. Clinical Deputy Director DAGRID/ODE/CDRH FOR
Erin I. Keith, M.S. Director Division of Anesthesiology. General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
510(k) Number (if known)
Device Name AF541 EE Full Face Mask
Indications for Use (Describe)
AF541 EE Leak 1 Mask
This Mask is intended to provide an interface for application of CP AP or bi-level therapy to patients. The mask is for single use in the hospital/institutional environment only. The mask is to be used on patients (-401bs) for whom CPAP or bi-level therapy has been prescribed.
AF541 EE Leak 2 Mask
This Mask is intended to provide an interface for application of CPAP or bi-level therapy to patients. The mask is for single use in the hospital/institutional environment and single patient use in the mask is to be used on patients (>40lbs/20kg) for whom CPAP or bi-level therapy has been prescribed.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
FORM FDA 3881 (8/14)
PSC Publishing Services (J01) 443-6740
Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.
3
510(k) Summary
510(k) Summary
| Date | March 9, 2015 |
|---|---|
| 510(k) Owner | Respironics, Inc. |
| 1001 Murry Ridge Lane | |
| Murrysville, PA 15668 | |
| (724) 387-7729 | |
| (724) 387-3999 (fax) | |
| Official Contact | Shaylee Masilunas |
| Regulatory Affairs Engineer | |
| Establishment | |
| Registration # | 2518422 |
| Proprietary Name | AF541 EE Full Face Mask |
| Common/Usual Name | Mask Accessory to a Non-Continuous Ventilator |
| Classification Panel | Anesthesiology Devices |
| Classification | |
| Reference | 21 CFR 868.5905 |
| Classification Name / | |
| Product Code | BZD - Ventilator, non-continuous (respirator) |
| Predicate Device(s) | AF531 EE Full Face Mask (K101130) |
Indications for Use
AF541 EE Leak 1 Mask
The AF541 EE Leak 1 Full Face Mask is intended to provide an interface for application of CPAP or bi-level therapy to patients. The mask is for single use in the hospital/institutional environment only. The mask is to be used on patients (>40lbs/20kg) for whom CPAP or bi-level therapy has been prescribed. AF541 EE Leak 2 Mask The AF541 EE Leak 2 Full Face Mask is intended to provide an interface for application of CPAP or bi-level therapy to patients. The mask is for single use in the hospital/institutional environment and single patient use in the home. The mask is to be
used on patients (>40lbs/20kg) for whom CPAP or bi-level therapy has been prescribed.
4
Device Description
The AF541 EE Full Face Mask is an oral-nasal full face mask that is available in various configurations (cushions and elbows). The AF541 EE Full Face has two cushion configurations, an Over the Nose (OTN) cushion and an Under the Nose (UTN) cushion. The following elbow configurations are available: EE Leak 1 and EE Leak 2. The Leak 1 and Leak 2 elbows have an anti-asphyxia valve. In addition, the Leak 2 elbow has built in exhalation to provide intentional leak when needed.
The AF541 EE Full Face Mask will have interchangeable cushions that attach to a common frame. There will be four sizes available for the nose option (S, M, L, XL). The UTN option will have three sizes available (A, B, C).
The AF541 mask will include a 4-point headgear and capstrap to allow for oral access with either headgear option. There will be 22 mm female mask frame. The AF541 OTN and UTN will be compatible with the EE Leak 1 and EE Leak 2 elbow.
Similarities and Differences of the Subject Device Compared to the Predicate Devices
The AF541 EE Full Face Mask has the following similarities to the previously cleared predicate devices AF531 EE Full Face Mask (K101130):
- Similar intended use ●
- Same operating principle .
- Similar design .
- Similar materials
- . Similar manufacturing process
The AF541 EE Full Face Mask has the following differences in the technological characteristics to the previously cleared predicate devices AF531 EE Full Face Mask (K101130):
- Product Code .
- Patient population
- Patient usage type ●
- Mask component design
- . Mask materials
5
510(k) Summary
Table 1: Comparison Table of Respironics AF541 EE Full Face Mask and predicate device
| Area | Predicate Device
AF531 EE Mask - Small Size
(K101130) | Subject Device
AF541 EE Full Face Mask |
|--------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Overview | | |
| Intended
Use | AF531 EE Leak 1 Mask The AF531 EE Leak 1 Full Face Mask is intended to provide an interface for application of CPAP or bi-level therapy to patients. The mask is for single use in the hospital/institutional environment only. The mask is to be used on patients 7 years or older (>40lbs/20kg) for whom CPAP or bi-level therapy has been prescribed. AF531 EE Leak 2 Mask The AF531 EE Leak 2 Full Face Mask is intended to provide an interface for application of CPAP or bi-level therapy to patients. The mask is for single use in the hospital/institutional environment only. The mask is to be used on patients 7 years or older (>40lbs/20kg) for whom CPAP or bi-level therapy has been prescribed. | AF541 EE Leak 1 Mask This Mask is intended to provide an interface for application of CPAP or bi-level therapy to patients. The mask is for single use in the hospital/institutional environment only. The mask is to be used on patients (>40lbs/20kg) for whom CPAP or bi-level therapy has been prescribed.
AF541 EE Leak 2 Mask This Mask is intended to provide an interface for application of CPAP or bi-level therapy to patients. The mask is for single use in the hospital/institutional environment and single patient use in the home. The mask is to be used on patients (>40lbs/20kg) for whom CPAP or bi-level therapy has been prescribed. |
| Patient
Population | 7 years or older (>40lbs/20kg) | (>40lbs/20kg) |
| Patient
Usage Type /
Environment
of Use | Single use in the hospital/institutional environment | EE Leak 1 - Unchanged from K101130.
EE Leak 2 – Single use in the hospital/institutional environment and single patient use in the home. |
| Product Code | MNS | BZD
The predicate device was classified with the Synchrony 2 BiPAP System as MNS. The AF531 and AF541 masks, as standalone devices, are classified under product code BZD. Unchanged from K101130. |
| Provided
Sterile or
Non-Sterile | Non-Sterile | Unchanged from K101130. |
| Area | Predicate Device
AF531 EE Mask - Small Size
(K101130) | Subject Device
AF541 EE Full Face Mask |
| Anatomical Sites | Nose and Mouth | Unchanged from K101130. |
| Entrainment Valve | The safety valve is integral to the
mask and opens to atmosphere in the
absence of therapy pressure. | Unchanged from K101130. |
| Device Design | 1. Faceplate/frame
2. Cushion
3. Elbow
4. Headgear
5. Headgear clips | 1. Frame
2. Cushion
3. Elbow
4. Headgear
5. Headgear talon clips |
| Sizes | One size - Small | Over the Nose (OTN) version has four
sizes (S, M, L, XL)
Under the Nose (UTN) version has
three sizes (A, B, C) |
6
510(k) Summary
Table 2: Material comparison for the Respironics AF541 EE Full Face Mask and its predicate device
| Component | Primary Predicate Device: | Subject Device: |
|---|---|---|
| AF531 EE Mask – Small Size | ||
| K101130 | AF541 EE Full Face Mask | |
| Manufacturer: | ||
| Respironics, Inc. | Manufacturer: | |
| Respironics, Inc. | ||
| Cushion | Silicone | Silicone |
| Frame | Polycarbonate | Polycarbonate |
| Elbow | Polypropylene | Polypropylene |
| Entrainment Valve | Polycarbonate | Polypropylene |
| Headgear/Capstrap | Nylon/Spandex, Polyurethane Foam | Nylon/Spandex, Polyurethane Foam |
New materials used in this mask are classified as external communicating, tissue contact, with a contact duration C (> 30 days cumulative). The following biocompatibility tests were completed:
- Muscle Implantation Study in Rabbits 4 Weeks ●
- . Muscle Implantation Study in Rabbits – 12 Weeks
- Genotoxicity: Bacterial Reverse Mutation Study ●
- Genotoxicity: Mouse Lymphoma Assay .
- Genotoxicity: Mouse Peripheral Blood Micronucleus Study .
- Intracutaneous Injection Test
- Kligman Maximization Test
- Agar Diffusion Test (Direct Contact) .
7
510(k) Summary
Design verification tests were performed on the AF541 EE Full Face Mask. All tests were verified to meet the required acceptance criteria. Respironics has determined that the modifications of the device have not raised new safety and effectiveness concerns. In summary, the device described in this submission is substantially equivalent to the predicate device.
Clinical Tests
Clinical tests were not required to demonstrate the substantial equivalence of the AF541 EE Full Face Mask. Product functionality has been adequately assessed by non-clinical tests.
Non-Clinical Tests
Performance testing was performed before and after cleaning treatments to verify that the device modifications of the subject device did not raise new safety and effectiveness concerns. Performance testing included:
- Total Mask Pressure Drop
- Total Mask Leak ●
- Intentional Leak ●
- Inspiratory & Expiratory Anti-Asphyxia Feature Resistance
- Anti-Asphyxia Feature Close to Atmosphere ●
- Anti-Asphyxia Feature Open To Atmosphere
- . Dead space
- . CO2 Rebreathing
- Storage Temperature and Humidity ●
- Cleaning Validation
The AF541 EE Full Face Mask has been designed per the following standards:
- ISO 17510-2 Sleep Apnoea Devices Part 2: Masks and Application Accessories . o Deviation
- Clause 5.3 Protection Against Rebreathing
- ISO 10993-1 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
- . ISO 14971 Medical devices - Application of risk management to medical devices
Conclusion
The performance and technological characteristics of the AF541 EE Full Face Mask are substantially equivalent to those of the AF531 EE Full Face Mask (K101130). The differences described above do not raise new questions of safety and effectiveness.